

IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application


(Sharecast News) - Respiratory drug development company Synairgen updated the market on its intellectual property for the wholly-owned inhaled interfe...


IN BRIEF: Synairgen Reports Promising Findings From SNG001 Trial


(Sharecast News) - Respiratory drug discovery and development company Synairgen announced positive data from the interim analysis of its exploratory p...


IN BRIEF: Synairgen Moving "Rapidly" To Get SNG001 Over Line


By Nancy LapidJuly 20 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to ...


LONDON MARKET CLOSE: FTSE 100 Lags Despite Encouraging Vaccine News


Synairgen Shares Soar On Positive Trial Results For Covid-19 Treatment